These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10697730)

  • 1. Production of 105Rh-EDTMP and its bone accumulation.
    Ando A; Ando I; Tonami N; Kinuya S; Okamoto N; Sugimoto M; Fukuda N; Matsumoto S
    Appl Radiat Isot; 2000 Feb; 52(2):211-5. PubMed ID: 10697730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 177Lu-EDTMP: a potential therapeutic bone agent.
    Ando A; Ando I; Tonami N; Kinuya S; Kazuma K; Kataiwa A; Nakagawa M; Fujita N
    Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and biological evaluation of 188Re-ethylenediamine-N,N,N',N'-tetrakis(methylene phosphonic acid) as a potential agent for bone pain palliation.
    Oh SJ; Won KS; Moon DH; Cheon JH; Ha HJ; Jeong JM; Lee HK
    Nucl Med Commun; 2002 Jan; 23(1):75-81. PubMed ID: 11748441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
    Das T; Chakraborty S; Sarma HD; Tandon P; Banerjee S; Venkatesh M; Pillai MR
    Nucl Med Biol; 2009 Jul; 36(5):561-8. PubMed ID: 19520297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
    Sohaib M; Ahmad M; Jehangir M; Perveen A
    Cancer Biother Radiopharm; 2011 Apr; 26(2):159-64. PubMed ID: 21510750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 227Th-EDTMP: a potential therapeutic agent for bone metastasis.
    Washiyama K; Amano R; Sasaki J; Kinuya S; Tonami N; Shiokawa Y; Mitsugashira T
    Nucl Med Biol; 2004 Oct; 31(7):901-8. PubMed ID: 15464392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 105Rh as a potential radiotherapeutic agent.
    Grazman B; Troutner DE
    Int J Rad Appl Instrum A; 1988; 39(3):257-60. PubMed ID: 2836343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
    Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
    Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of (166)Dy/(166)Ho-EDTMP: a potential in vivo generator system for bone marrow ablation.
    Pedraza-López M; Ferro-Flores G; de Murphy CA; Tendilla JI; Villanueva-Sánchez O
    Nucl Med Commun; 2004 Jun; 25(6):615-21. PubMed ID: 15167523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiochemical studies, pre-clinical investigation and preliminary clinical evaluation of
    Das T; Shinto A; Kamaleshwaran KK; Sarma HD; Mohammed SK; Mitra A; Lad S; Rajan MGR; Banerjee S
    Appl Radiat Isot; 2017 Apr; 122():7-13. PubMed ID: 28088002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
    Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
    J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal dosimetry studies of
    Shirmardi SP; Saniei E; Das T; Noorvand M; Erfani M; Bagheri R
    Appl Radiat Isot; 2020 Dec; 166():109396. PubMed ID: 32889376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radiopharmaceuticals.
    Garnuszek P; Pawlak D; Licińska I; Kamińska A
    Appl Radiat Isot; 2003 Apr; 58(4):481-8. PubMed ID: 12672628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
    Keeling AA; Vaughan AT; Beaney RP
    Br J Cancer; 1989 Jul; 60(1):74-8. PubMed ID: 2803919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model.
    Louw WK; Dormehl IC; van Rensburg AJ; Hugo N; Alberts AS; Forsyth OE; Beverley G; Sweetlove MA; Marais J; Lötter MG; van Aswegen A
    Nucl Med Biol; 1996 Nov; 23(8):935-40. PubMed ID: 9004281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and biological evaluation of 153Sm-DOTMP as a potential agent for bone pain palliation.
    Chakraborty S; Das T; Banerjee S; Chaudhari PR; Sarma HD; Venkatesh M; Pillai MR
    Nucl Med Commun; 2004 Dec; 25(12):1169-76. PubMed ID: 15640774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
    Brenner W; Kampen WU; Kampen AM; Henze E
    J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation.
    Chakraborty S; Das T; Unni PR; Sarma HD; Samuel G; Banerjee S; Venkatesh M; Ramamoorthy N; Pillai MR
    Nucl Med Commun; 2002 Jan; 23(1):67-74. PubMed ID: 11748440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts.
    Toegel S; Hoffmann O; Wadsak W; Ettlinger D; Mien LK; Wiesner K; Nguemo J; Viernstein H; Kletter K; Dudczak R; Mitterhauser M
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):491-4. PubMed ID: 16416330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of bone seeker radiopharmaceuticals by Scandium-47 and estimation of human absorbed dose.
    Deilami-Nezhad L; Moghaddam-Banaem L; Sadeghi M
    Appl Radiat Isot; 2017 Nov; 129():108-116. PubMed ID: 28843158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.